Nogo-B is associated with the progression of gastric cancer, hepatocellular carcinoma and other carcinomas, contributing to angiogenesis, inflammation and lipid metabolism [14, 16, 17]. This evidence concerns the gene RTN4 and hepatocellular carcinoma.